Within a quiet part on the campus of the Faculty of Medicine and Odontostomatology at Point G, a technological revolution is taking place every day. It was here, at the Molecular Biology and Genomics Laboratory, that the first cases of COVID-19 were diagnosed in Mali in March 2020.EN-VIDEO HERE
Today, thanks to the experience acquired during the Ebola and coronavirus crises, this high-precision facility equipped with new-generation sequencing platforms does more than just screen; it decodes. Whether for dengue, Mpox, or hemorrhagic viruses, the team of highly qualified experts characterizes or determines variants with a high degree of accuracy.
This laboratory is not just about diagnosis and sequencing; it also conducts studies on factors such as immune response and antibiotic resistance, to understand why some individuals are more vulnerable to viruses or bacteria. This research helps identify new therapeutic targets to COMBAT antibiotic resistance, i.e., COMBAT the ability of bacteria to resist the action of antibiotics, which are drugs that treat infections, making them ineffective.
This laboratory also welcomes graduate students in medicine and pharmacy who conduct cutting-edge research for their theses, particularly on antimicrobial resistance, which refers to the ineffectiveness of drugs in treating infections, as well as on population genetics.
Working hand in hand with the National Institute of Public Health (INSP) and benefiting from the ongoing support of the US National Institutes of Health (NIH), the UCRC laboratory is providing long-term support to the efforts of the Ministry of Health and Social Development.
UCRC/USTTB Communication Office
- Join us on YOUTUBE
- Join us on LINKEDIN
- Join us on X-PAGE
